Real World Evidence (Video Content)

Healthcare payers, including national governments, continue to face enormous cost and capacity challenges largely as a result of increasing demand from growing numbers of older people with multiple, complex conditions and the rise in non-communicable lifestyle diseases such as diabetes. Treatment costs are rising alongside this, partly due to the challenges in developing products which are targeted at complex disease states and patient sub-populations. In order to continue delivering the best possible outcomes for patients, it is vital that new ways are found to enable therapeutics to be brought to market at a sustainable cost.

self

Opportunities presented by Real World Evidence

Healthcare data present a unique opportunity to develop real world evidence insights into existing diagnostic and treatment pathways, to identify unmet need and to demonstrate the actual clinical and economic impact of interventions within the healthcare system. This evidence enables R&D organisations to prioritise their pipeline investments more effectively, better understand underlying causes of disease and identify opportunities for indication expansion and business development. It allows commercial organisations to demonstrate the clinical and economic value of their products to payers, to deploy health solutions that truly integrate healthcare and therapeutics and to build new reimbursement mechanisms.

Download

Real World Evidence: Transforming patient care (1.18MB PDF)

Building stakeholder trust in use of health data

The development of real world evidence is therefore essential to sustain...